贝瑞基因
(000710)
| 流通市值：33.15亿 | | | 总市值：34.93亿 |
| 流通股本：3.36亿 | | | 总股本：3.54亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 235,776,769.95 | 301,591,814.38 | 379,511,612.5 | 309,746,339.92 |
| 交易性金融资产 | 2,821,047.91 | 2,821,047.91 | 2,821,047.91 | 10,479,041.92 |
| 应收票据及应收账款 | 561,898,785.18 | 558,523,140.24 | 547,818,540.5 | 647,101,558.28 |
| 其中：应收票据 | 7,987,080 | 10,310,056 | 11,749,620 | 11,750,786.08 |
| 应收账款 | 553,911,705.18 | 548,213,084.24 | 536,068,920.5 | 635,350,772.2 |
| 应收款项融资 | 937,147 | 1,214,032 | 1,214,032 | - |
| 预付款项 | 24,785,270.21 | 19,798,554.44 | 10,266,629.01 | 28,338,876.96 |
| 其他应收款合计 | 51,615,478.33 | 50,143,477.52 | 56,045,100.84 | 66,582,468.77 |
| 存货 | 176,303,543.75 | 178,028,969.89 | 176,762,911.21 | 183,664,494.31 |
| 一年内到期的非流动资产 | 293,701.48 | 298,570.86 | 305,425.19 | 446,835.78 |
| 其他流动资产 | 77,193,999.52 | 64,567,857.93 | 69,336,994.62 | 51,699,534.4 |
| 流动资产合计 | 1,131,625,743.33 | 1,176,987,465.17 | 1,244,082,293.78 | 1,298,059,150.34 |
| 非流动资产: | | | | |
| 长期应收款 | - | - | - | 308,725.55 |
| 长期股权投资 | 194,523,216.44 | 194,244,150.7 | 187,753,328.24 | 188,314,680.58 |
| 固定资产 | 393,997,297.84 | 391,307,087.26 | 392,800,348.56 | 388,770,454.2 |
| 在建工程 | 13,669,583.21 | 9,514,203.25 | 9,514,203.25 | 14,543,288.63 |
| 使用权资产 | 107,172,481.38 | 112,260,452.52 | 117,595,294.96 | 137,643,859.35 |
| 无形资产 | 62,359,495.36 | 64,296,836.14 | 66,398,968.98 | 29,170,866.83 |
| 开发支出 | 12,866,582.15 | 11,551,466.63 | 10,656,928.46 | 46,446,461.1 |
| 商誉 | 13,433,638.57 | 13,433,638.57 | 13,433,638.57 | 13,433,638.57 |
| 长期待摊费用 | 84,136,823.47 | 91,726,517.42 | 91,583,114.62 | 51,243,796.81 |
| 递延所得税资产 | 148,224,872.68 | 150,442,094.95 | 150,418,827.69 | 145,668,147.64 |
| 其他非流动资产 | - | - | - | 30,107,692.48 |
| 非流动资产合计 | 1,030,383,991.1 | 1,038,776,447.44 | 1,040,154,653.33 | 1,045,651,611.74 |
| 资产总计 | 2,162,009,734.43 | 2,215,763,912.61 | 2,284,236,947.11 | 2,343,710,762.08 |
| 流动负债: | | | | |
| 短期借款 | 108,641,229.77 | 155,083,494.6 | 154,316,818.87 | 152,448,975.65 |
| 应付票据及应付账款 | 230,623,991.01 | 211,383,884.63 | 272,907,048.88 | 217,216,977.66 |
| 其中：应付票据 | - | - | - | 830,340 |
| 应付账款 | 230,623,991.01 | 211,383,884.63 | 272,907,048.88 | 216,386,637.66 |
| 合同负债 | 117,222,245.03 | 120,804,129.46 | 119,661,876.77 | 96,914,800.85 |
| 应付职工薪酬 | 37,844,831.64 | 44,440,105.54 | 45,703,346.57 | 37,423,170.39 |
| 应交税费 | 10,548,875.37 | 1,060,577.99 | 9,744,031.42 | -4,188,193.13 |
| 其他应付款合计 | 10,506,148.38 | 11,784,138.47 | 13,559,567.64 | 13,215,296.01 |
| 一年内到期的非流动负债 | 11,471,730.04 | 6,314,331.52 | 11,550,500.44 | 3,032,218.73 |
| 其他流动负债 | 6,408,144.54 | 8,677,227.55 | 8,551,284.19 | 4,978,596.38 |
| 流动负债合计 | 533,267,195.78 | 559,547,889.76 | 635,994,474.78 | 521,041,842.54 |
| 非流动负债: | | | | |
| 长期借款 | 10,008,055.56 | - | - | - |
| 租赁负债 | 98,853,642.34 | 108,428,588.72 | 107,285,083.81 | 136,604,120.59 |
| 长期应付款 | 30,000,000 | - | - | - |
| 递延收益 | 11,029,000 | 11,029,000 | 10,942,000 | 10,992,000 |
| 递延所得税负债 | 25,008,633.66 | 25,968,363.72 | 25,922,738.97 | 25,796,262.41 |
| 非流动负债合计 | 174,899,331.56 | 145,425,952.44 | 144,149,822.78 | 173,392,383 |
| 负债合计 | 708,166,527.34 | 704,973,842.2 | 780,144,297.56 | 694,434,225.54 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 353,521,465 | 353,521,465 | 353,521,465 | 353,521,465 |
| 资本公积 | 1,158,313,963.34 | 1,162,635,836.75 | 1,162,635,836.75 | 1,154,493,596.63 |
| 其他综合收益 | 10,577,207 | 12,924,310.91 | 16,405,344.99 | 18,779,509.05 |
| 盈余公积 | 80,849,357.82 | 80,849,357.82 | 80,849,357.82 | 80,849,357.82 |
| 未分配利润 | -181,114,270.55 | -156,904,548.6 | -137,166,395.5 | 11,978,659.79 |
| 归属于母公司股东权益合计 | 1,422,147,722.61 | 1,453,026,421.88 | 1,476,245,609.06 | 1,619,622,588.29 |
| 少数股东权益 | 31,695,484.48 | 57,763,648.53 | 27,847,040.49 | 29,653,948.25 |
| 股东权益合计 | 1,453,843,207.09 | 1,510,790,070.41 | 1,504,092,649.55 | 1,649,276,536.54 |
| 负债和股东权益合计 | 2,162,009,734.43 | 2,215,763,912.61 | 2,284,236,947.11 | 2,343,710,762.08 |
| 公告日期 | 2026-08-24 | 2026-04-30 | 2026-04-29 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |